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What is already known about this subject? 
 Obstructive sleep apnoea in the severely obese pregnant population is under-
researched yet has potentially severe maternal and fetal consequences. 
 Data regarding prevalence of OSA in pregnancy is scarce, although the 
estimated rate in women of reproductive age is 5-6%. 
 The reliability of screening methods is variable, particularly when used in 
pregnant women.  
What this study adds? 
 12% of 162 obese pregnant women scored positively on the Epwoth 
Sleepiness Scale (ESS), but this was not confirmed on formal testing using 
more invasive techniques.  
 Neither the ESS questionnaire nor the RUSleeping (RUS) meter appeared to 
provide a reliable method with which to diagnose OSA in pregnancy.  
 Larger studies using screening questionnaires coupled with updated and less 
invasive monitoring technology are required before prevalence of OSA in 
pregnancy can be reliably estimated. 
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Abstract  
Introduction 
Obstructive sleep apnoea is an often-overlooked diagnosis, more prevalent in the 
obese population. Screening method accuracy, uptake and hence diagnosis is variable. 
There is limited data available regarding the obese pregnant population, however 
many studies highlight potential likely risks of apnoeic episodes, both to the mother 
and fetus, including hypertension, diabetes and pre-eclampsia.  
 
Materials and Methods 
162 women with a BMI≥35 were recruited from a tertiary referral hospital in the 
North West of England. They were invited to attend three research antenatal clinics, 
completing an Epworth sleepiness scale (ESS) questionnaire at each visit. A monitor 
to measure the apnoea hypopnoea index (AHI) was offered at the second visit. Data 
taken from consent forms, hospital notes and hospital computer records were collated 
and anonymised prior to statistical analysis. 
 
Results  
12.1% of women had an ESS score of ≥10, suggesting possible OSA. Rates increased 
throughout pregnancy although unfortunately there was a high rate of attrition. 37.6% 
of women used the RUSleeping meter; only one (2.1%) met prespecified criteria for 
OSA (AHI≥15). This individual had OSA categorised as severe and underwent 
investigations for preeclampsia, eventually delivering by emergency caesarean section 
due to foetal distress. 
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Conclusions 
The accuracy of the ESS questionnaire to detect OSA in the pregnant population 
remains unclear. Further research on a larger sample size using more user-friendly 
technology to measure AHI would be beneficial. There are currently no guidelines 
relating to screening for OSA in the obese pregnant population, yet risks to both 
mother and foetus are well researched.  
 
Abbreviations 
Obstructive sleep apnoea (OSA), Apnoea hypopnea index (AHI), Epworth sleepiness 
scale (ESS), Body Mass Index (BMI), American Academy of Sleep Medicine 
(AASM) 
 
Key Message  
Obstructive sleep apnoea in the severely obese pregnant population is under-
researched yet has potentially severe maternal and fetal consequences. Simple 
screening methods leading to early diagnosis are likely to be beneficial.  
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Main text  
Sleep disordered breathing (SDB) covers a spectrum of symptoms ranging from 
snoring and upper airway resistance syndrome to obstructive sleep apnoea (OSA). 
Diagnosis of OSA depends on the average number of apneas and hypopneas per hour 
of sleep, also known as the Apnea Hypopnea Index (AHI). OSA is diagnosed when 
there are clinical symptoms plus AHI ≥ 5. Although there have been many studies 
into OSA in the general population, there is limited information regarding the 
prevalence and usefulness of screening tools to detect OSA in pregnant women. (1,2) 
 
Classical symptoms include excessive daytime sleepiness, gasping or choking 
sensations during sleep and witnessed apneas.  Daytime symptoms such as drowsiness 
are rather non-specific. In pregnancy this is further complicated as many women 
experience reduced quality sleep and impaired daytime functioning for other 
physiological reasons i.e. nocturia, discomfort, pain and general restlessness. (1,3) As 
a consequence, many believe that poor sleep and excessive daytime somnolence is 
normal during pregnancy, which can delay or even prevent presentation to a health 
care professional and the subsequent investigation into these symptoms. (4) Compared 
with men, women are more likely to mention lack of energy or fatigue when 
describing symptoms, and this can exaggerate scores on screening questionnaires. 
Depression and hypothyroidism can also increase ESS scores, which further 
complicates diagnosis. (5,6) 
There are a number of mechanisms believed to increase the risk of OSA in pregnancy. 
OSA has a strong association with increased BMI, as does progressive weight gain in 
pregnancy. As the fetus grows, it displaces the diaphragm upwards and reduces lung 
functional residual capacity by up to 20%. Furthermore increased oestrogen levels 
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may lead to a narrowing of the upper airway due to vasomotor rhinitis, nasopharyneal 
mucosal oedema and hyperaemia. (1,7) 
 
Data regarding prevalence of OSA in pregnancy is scarce, and accurate rates are not 
yet known. Prevalence in women of reproductive age is estimated to be between 5-
6%. (1) A small, prospective cohort study of 105 pregnant women in America showed 
10.5% had OSA in first trimester and 26.7% in third, using formal overnight 
polysomnography testing. Of the 28 women with definitive OSA in the third 
trimester, it was mild in 23, moderate in 4 and severe in 1. Women were not 
statistically representative of the general obstetric population but did have equally 
distributed BMI values. (8,9) 
 
Although pregnancy is thought to increase risk of OSA, Sarberg et al studied 180 
women using the Epworth Sleepiness Scale (ESS) and ‘whole night respiratory 
recordings’ and demonstrated lower rates of OSA in pregnant (1%) versus a control 
group (3%) of age and BMI-matched non-pregnant women. Interestingly, the ESS 
median score was 7 in non-pregnant group and 9 in pregnant group (p<0.001) 
suggesting that the ESS may overestimate the rate of OSA when used for the 
screening of the pregnant population. It is important to recognize however, that the 
majority of women in this study were non-obese. (10) 
 
OSA in pregnancy carries significant risks maternal and fetal risks, including 
intrauterine growth restriction, pulmonary hypertension, gestational diabetes mellitus, 
and preeclampsia. (11-15) For example, Chen et al analysed data from 791 women 
with OSA and 3955 randomly selected women without OSA. They found that 
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pregnant women with OSA were at increased risk for having preeclampsia, as well as 
growth restricted and preterm babies. (11) 
 
There are a number of screening questionnaires available for detecting those at risk of 
OSA including the ESS, Berlin, Stop and Stop-Bang questionnaires. Although 
questionnaires are both economical and accessible, they have had variable success in 
previous studies. A comparative study of all four using 234 patients referred to a sleep 
clinic demonstrated high sensitivity rates for the Berlin, Stop and Stop-Bang 
questionnaires (95%, 91% and 98%) but low specificity rates (25% 25% and 26%). 
The ESS had the highest specificity (75%) but lowest sensitivity (73%). (16) Other 
studies have shown better performance of questionnaires, particularly in the second 
and third trimesters. (17) 
 
ESS scores tend to increase throughout pregnancy. Sarberg et al found the mean ESS 
score increased from 7.9 to 8.7 from 1st to 3rd trimester (p<0.001.) (18) Similar 
outcomes were found by Hutchison et al: 4% had ESS score ≥10 pre-pregnancy, 
compared to 33% in final week of pregnancy. (4) Pien et al found the ESS scores 
increased significantly at all subsequent assessments during pregnancy but there was 
no significant association found between baseline BMI and ESS scores. This study 
did not note any weight changes during pregnancy. (19) 
 
For formal diagnosis, the gold standard is overnight, observed 24-hour 
polysomnography as per American Academy of Sleep Medicine (AASM) guidelines. 
(2,20) A cheaper and technically simpler alternative is a wrist-worn monitor such as 
Watch-Pat 200. (17) The RUSleeping monitor (Philips Respironics, The Netherlands) 
 8 
used in this study is worn on the face and monitors changes in nasal pressure to detect 
respiratory events. (21) It has been classified as a single-channel ASDA level IV 
device and gives an hourly and cumulative AHI score. A study of 25 adults with 
suspected OSA demonstrated good agreement between data collected by the RUS 
meter and a standard multi-channel polysmonogram (R=0.77, p<0.001.) with high 
sensitivity (89%) and specificity (86%). (21) However, there is no previous data on 
the use of the RUS meter during pregnancy.  
 
This study aims to investigate the prevalence of OSA in obese, pregnant woman using 
the ESS questionnaire to identify those with symptoms and the RUS meter to provide 
definitive data. Accurate identification of those with OSA will help ensure correct 
treatment and management to help reduce rates of complications. 
 
Materials and methods 
The Fit for Birth study was a cohort study of pregnant women with a BMI of ≥30. 
Detailed information is available elsewhere (Narayanan et al 2016) but in brief 824 
women were recruited over a one-year period in a large tertiary referral hospital in the 
northwest of England. (22) Data was collected for all those in the study who 
subsequently gave birth at the trust.  
 
For this nested study on OSA in pregnancy (the ‘Fit for Birth PLUS’ study), 
additional data was collected from 162 women with BMI ≥35. These women attended 
a research antenatal clinic 3 times during their pregnancy, and changes in weight 
during pregnancy were recorded along with data on diet, activity, sleep and quality of 
life. Visits were made at approximately 16 weeks, 28 weeks and 36 weeks gestation. 
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This paper focuses on the sleep data that was collected using Epworth Sleepiness 
Scale (ESS) questionnaires completed at each trimester visit plus data collected by the 
RUS meter offered at approximately 28 weeks gestation. Ethical approval was 
obtained from Liverpool (Adult) Research Ethics Committee (09/H1005/23) and each 
woman gave individual informed consent for participation. 
 
The Epworth Sleepiness Scale is a standardised questionnaire that measures the 
probability of falling asleep in eight situations. (23) Candidates rank the likelihood 
from 0 to 3, with 0 being extremely unlikely to fall asleep and 3 being very likely. 
The maximum score is 24 and ≥10 is considered abnormal, requiring further 
investigation. It has previously been validated for use in the general population and 
has been used in other studies on pregnant women. (24)  
 
The RUSleeping RTS meter (Philips Respironics, The Netherlands) is a screening 
device worn on the face that monitors changes in nasal pressure to detect respiratory 
events. At approximately 28 weeks, study participants were asked to use the 
RUSleeping meter overnight at home as an objective and instrumental means of 
measuring apnoea and hypnoea events in the least intrusive way available at the time. 
An AHI ≥15 was used as an indication for further investigation.  
 
Data Analysis 
All data taken from consent forms, hospital notes and the hospital’s computer records 
(MEDITECH) were collated and anonymised prior to statistical analysis. Analyses 
were carried out in Intercooled Stata11 (Statcorp, College Station, TX, USA). SPSS 
was used to analyse change in Epworth Sleepiness Scale scores throughout 
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pregnancy. The random effects model was used to model change in Epworth scores 
over time.  
 
Results 
Data from 162 women was analysed. Their mean age was 29.6 (range 18-43, SD 6.1) 
and median BMI was 38 (range 35-68.6; Table I). Full details of the cohort are 
published elsewhere. (22) 
 
Of the 162 who joined the nested ‘Fit for Birth PLUS’ study, 77 women (47.5%) had 
a complete data set having attended all 3 clinics and having completed the ESS at 
each of these. Only 47 women completed the use of the RUS meter. (Figure I) 
  
The overall rate of women with an ESS score of ≥ 10 was 12.1% with increasing rates 
through pregnancy (table II).  
 
Women who were smokers at the time of booking reported slightly higher scores 
(+1.7) but this is statistically marginal (p=0.04). Several other covariates were 
investigated and found not to be significant including BMI, weight change, baby’s 
birthweight and hypertension. 
 
Further descriptive analysis was undertaken to examine individual ESS questions 
whose findings demonstrate inconsistency within the overall questionnaire results 
(table III).  
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A total of 77 women completed ESS questionnaires at all three clinic visits. A 
repeated measures ANOVA with a Greenhouse-Geisser correction found that the 
mean Epworth score increased with gestation (M=4.67, M=5.44, M=5.86). This was 
statistically significant between trimester one and two and between trimester one and 
three (p=0.009). When comparing solely data from women who visited clinic one and 
three, the average change in Epworth score was 0.95 (SD=3.7).  
 
There was substantial individual variation between the women in both average score 
and trend over time. Some increased in score over time, some scores remained flat 
and some decreased. A random effects model confirmed that the overall scores tended 
to increase by about 0.058 per week of gestation (approx. 1.2 over 20 weeks 
gestation) and that the overall average scores and the rates of change varied from 
woman to woman. In general, the average score was negatively correlated to the 
direction of change; those with the higher average scores were those with scores that 
tended to decrease over the visits. 
 
The uptake of women prepared to use the RUS meter was poor. Of the 47 who did use 
the meter, only one had an AHI index of ≥15. The reasons given for not using the 
meter are given in table IV.  
 
Out of a possible 125 women who attended this second visit clinic, 47 (37.6%) took 
the meter home, used it and returned the results. Only 1 of 47 (2.1%) had a score ≥15 
which demonstrated a preliminary diagnosis and need for further investigation and 
likely intervention. This participant had an AHI score of 42.6, which corresponds to 
the severe OSA category (score ≥30). She attended all three clinics and has ESS 
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scores of 5, 10 and 21. She had numerous risk factors for and associations with OSA 
including increased maternal age (39), BMI ≥ 35 and a coexisting mental health 
disorder. During the time between clinics two and three, she was admitted to the 
hospital due to raised BP and proteinuria although later discharged. She was 
eventually induced at 38 weeks gestation and delivered a healthy baby by emergency 
caesarean section for fetal distress. 
 
Discussion 
In this study of 162 obese pregnant women with a BMI >35, there was a 12.1% rate 
of OSA as determined by an ESS questionnaire score of ≥10. This risk increased 
significantly with each trimester, but did not correlate to booking BMI, weight 
change, baby birthweight or hypertension. Of those using the RUS meter, the rate of 
OSA was 2.1%. 
 
The findings of this study are complicated by factors that may cause ESS scores to 
rise during pregnancy irrespective of OSA. ESS scores may be falsely highly reported 
particularly in women due to the difference of symptom presentation.  ESS scores 
may also be under-reported in the pregnant population due to commitments with 
caring for young families and work commitments. The negative correlation between 
average score and direction of ESS score change might be one aspect that could have 
been influenced by this confounding factor. There is also an accepted belief that poor 
sleep and excessive daytime somnolence is part of a normal pregnancy. (4) 
 
NICE recommend the ESS questionnaire as a screening tool for the non-pregnant 
population, with referral advised if symptomatic plus ESS score >10. (25) However 
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there are no studies that specifically assess the ESS questionnaires on the pregnant, 
obese population. Comparative data is therefore lacking. 
 
Responses to individual questions within the ESS were of interest. As expected, 
nearly no-one reported a “Likelihood of dozing when sitting & talking to someone” or 
“Likelihood of dozing when in a car, stopped at traffic lights”. For others, answers 
were very variable. For example, “Likelihood of dozing when lying down to rest in 
afternoon” had an even spread of results where it might have been assumed that many 
pregnant women given the chance, would have easily dozed at this point. Many 
women voiced the view that they would never get chance to lie down in the afternoon 
due to their other offspring needing attention. These pregnancy specific responses 
suggest that the ESS may not be as robust during pregnancy. Baumgartel et al take the 
view that the ESS should be scored using two parts: sleepiness in appropriate and 
inappropriate situations. High scores of sleepiness in inappropriate situations could 
indicate higher risks of further complications in pregnancy. (26) 
 
In this study, a score of ≥15 using the RUS meter was used to preliminarily diagnose 
OSA. This device is a relatively untested method of assessing OSA and had a high 
rate of non-compliance. Although thorough education was provided on ideal 
techniques for use, the sleep was unobserved so it is difficult to ascertain the validity 
of the results achieved. In 2009, RUS meter was considered the most appropriate and 
cost-effective device to measure apnoeic/hypopnoeic episodes, however, with 
advancing technology, future studies could achieve better compliance with a newer, 
less intrusive wrist worn device, for example the Watch-Pat 200. (17) Gold standard 
investigation as defined by AASM guidelines to diagnose OSA is overnight observed 
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polysomnography testing, however this is an impractical and expensive alternative. 
(1) 
 
Of the 47 participants using the RUS meter, one had an AHI score of ≥15 (2%). 
Interestingly, her score was 42.6 placing her in the severe OSA category. She had a 
complicated pregnancy and delivery including investigations for pre-eclampsia and 
the need for an emergency C-section due to fetal distress. These complications have 
all been found to be associated with OSA. (13-15) There are no other studies using 
the RUS meter in pregnancy. However, a study of 25 non-pregnant adults referred to 
a sleep centre with OSA found 18 participants (72%) had an AHI ≥5 and only 5 
(25%) had an AHI ≥30. (21) It is difficult to compare these two studies directly and 
ultimately due to substantial technological advances over recent years the use of the 
RUS meter has been largely replaced by superior alternatives. 
 
There were a number of weaknesses identified following the implementation of this 
study. There was a high rate of attrition, with reasons not documented and unable to 
be ascertained. There is no evidence that women with high Epworth scores were less 
likely to attend the research clinics, although it is plausible that women with higher 
scores will be more tired during the day and hence less able to make appointments. 
There was also a high rate of non-compliance with the RUS meter, making it difficult 
to link results from the ESS questionnaire to the RUS meter results. 
 
In conclusion, this study has found that 12% of obese pregnant women scored 
positive on the ESS, but this was not confirmed on formal testing using more invasive 
techniques. Although OSA in pregnancy is important, this study identified problems 
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with both the ESS and the RUS meter and neither appeared to provide a reliable 
method with which to diagnose OSA in pregnancy. Larger studies are needed before a 
reliable estimate of the prevalence of OSA in pregnancy is made. 
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Tables 
 
Table I: BMI of the study participants 
BMI category Total number (%) 
35-39.9 94 (58%) 
40-44.9 41 (25.3%) 
45+ 27 (16.7%) 
 
Table II: Summary ESS scores 
 
n 
Mean score 
(SD; range) 
ESS ≥ 10 
1st visit – 16 weeks 143 4.82 
(3.66; 0-19) 
10 (7.0%) 
2nd visit – 28 weeks 125 5.30 
(3.85; 0-20) 
15 (12.0%) 
3rd visit – 36 weeks 93 5.87 
(4.10; 0-21) 
16 (17.2%) 
 
 
 
 
 
 
 
 20 
Table III: Responses to selected questions within the ESS. 
 
“Likelihood of dozing when sitting & talking to someone” 
 
Score 0 (% of total responders) Score 3 
Visit 1 (n = 143) N=135 (94.4%) N=1 (0.7%) 
Visit 2 (n = 125) N=117 (94.3%) N=0 
Visit 3 (n = 93) N=83 (91.2%) N=0 
 
 
“Likelihood of dozing when in a car, stopped at traffic lights” 
 
Score 0 (% of total responders) Score 3 
Visit 1 (n = 143) N=137 (95.8%) N=0 
Visit 2 (n = 125) N=117 (94.3%) N=1 (0.8%) 
Visit 3 (n = 93) N=84 (92.3%) N=0 
 
“Likelihood of dozing when lying down to rest in afternoon” 
 Score 0 (% of total responders) Score 3 
Visit 1 (n = 143) N=11 (7.4%) N=46 (31.1%) 
Visit 2 (n = 125) N=16 (12.9%) N=38 (30.6%) 
Visit 3 (n = 93) N=9 (9.9%) N=28 (28%) 
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Table IV: Reason for non-compliance with RUS meter 
 
Reason for non-compliance  
 
Total number Percentage of total 
non-compliant  
Declined (various reasons: anxiety, unwell, 
didn’t see the point, didn’t like the idea, not 
interested etc.) 
41 25.3% 
No meters available to give out 13  8.0% 
Didn’t return/returned not used  12  7.4% 
Not asked to take meter by satellite clinic 9  5.6% 
Not asked due to language barrier 1  0.6% 
 
 
Figures 
Figure I: Numbers of participating women attending each clinic 
 
Women in fit for birth 
PLUS subset (n=162)
Attending clinic at 16 
weeks and completing 
ESS 
(n=143) 86.6%
Attending clinic at 28 
weeks and completing 
ESS (n=125) 77.2%
Uptake of RUS meter 
(n=47) 29.0%
Attending clinic at 36 
weeks and completing 
ESS (n=93) 57.4%
